Compass Therapeutics, Inc.
Total Trades
33
Buys
29
Sells
4
Largest Trade
$1M+
Insiders
6
Institutional Funds
122
Inst. Value
$1M+
Activist Filings
28
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $15K–$50K | 10K | $2.11 | May 27, 2025 |
| GORDON CARL L | Director | SELL | $1M+ | 3.6M | $1.59 | Apr 11, 2025 |
| ORBIMED ADVISORS LLC | Director | SELL | $1M+ | 3.6M | $1.59 | Apr 11, 2025 |
| Anderman Jonathan | Gen Counsel & Corp… | BUY | $15K–$50K | 20K | $1.54 | Apr 8, 2025 |
| Lerner Neil | CHIEF ACCOUNTING O… | BUY | $15K–$50K | 20K | $1.42 | Apr 8, 2025 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $15K–$50K | 10K | $3.37 | Mar 10, 2023 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $50K–$100K | 20K | $3.98 | Feb 27, 2023 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $50K–$100K | 20K | $3.86 | Feb 15, 2023 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $50K–$100K | 20K | $4.05 | Jan 31, 2023 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $50K–$100K | 20K | $4.19 | Jan 24, 2023 |
| Bisker-Leib Vered | COO | SELL | $100K–$500K | 25K | $4.23 | Nov 25, 2022 |
| Bisker-Leib Vered | COO | SELL | $50K–$100K | 22K | $4.36 | Nov 22, 2022 |
| ORBIMED ADVISORS LLC | Director | BUY | $1M+ | 402K | $3.21 | Nov 10, 2022 |
| GORDON CARL L | Director | BUY | $1M+ | 402K | $3.21 | Nov 10, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $15K–$50K | 10K | $2.32 | Sep 28, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $15K–$50K | 15K | $2.27 | Sep 27, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $15K–$50K | 15K | $3.03 | Sep 8, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $15K–$50K | 15K | $2.83 | Sep 1, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $15K–$50K | 15K | $3.05 | Aug 17, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $15K–$50K | 15K | $2.64 | Aug 10, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $15K–$50K | 15K | $2.58 | Aug 2, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $50K–$100K | 20K | $2.80 | Jun 21, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $15K–$50K | 20K | $2.34 | Jun 17, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $50K–$100K | 30K | $2.29 | Jun 13, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $50K–$100K | 20K | $3.03 | Jun 1, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $50K–$100K | 20K | $3.04 | May 26, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $15K–$50K | 18K | $2.72 | May 24, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $15K–$50K | 20K | $2.47 | May 17, 2022 |
| GORDON CARL L | Director | BUY | $100K–$500K | 193K | $2.18 | May 13, 2022 |
| ORBIMED ADVISORS LLC | Director | BUY | $100K–$500K | 193K | $2.18 | May 13, 2022 |
| ORBIMED ADVISORS LLC | Director | BUY | $100K–$500K | 125K | $1.57 | May 10, 2022 |
| GORDON CARL L | Director | BUY | $100K–$500K | 125K | $1.57 | May 10, 2022 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OF… | BUY | $50K–$100K | 28K | $1.80 | May 10, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 122 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 16.8M | $1M+ | SH |
| ORBIMED ADVISORS LLC | 15.2M | $1M+ | SH |
| Vivo Capital, LLC | 9.5M | $1M+ | SH |
| M&T BANK CORP | 646K | $1M+ | SH |
| Enavate Sciences GP, LLC | 7.8M | $1M+ | SH |
| VANGUARD GROUP INC | 7.0M | $1M+ | SH |
| STATE STREET CORP | 4.9M | $1M+ | SH |
| Blue Owl Capital Holdings LP | 3.5M | $1M+ | SH |
| Blue Owl Capital Holdings LP | 3.5M | $1M+ | SH |
| Sofinnova Investments, Inc. | 3.4M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 3.0M | $1M+ | SH |
| BRAIDWELL LP | 2.8M | $1M+ | SH |
| Palo Alto Investors LP | 2.5M | $1M+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 1.6M | $1M+ | SH |
| Birchview Capital, LP | 1.6M | $1M+ | SH |
| Trails Edge Capital Partners, LP | 1.4M | $1M+ | SH |
| MARSHALL WACE, LLP | 1.3M | $1M+ | SH |
| Logos Global Management LP | 1.1M | $1M+ | SH |
| NEXTBio Capital Management LP | 1.1M | $1M+ | SH |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.1M | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Blackstone Annex Master Fund L.P.
SC 13G/A · Feb 13, 2026
1.4%
2.4M shares
SC 13G · Jan 21, 2026
5.2%
9.3M shares
Vivo Opportunity Fund Holdings, L.P.
SC 13G · Nov 14, 2025
5.1%
9.0M shares
SC 13G/A · Nov 14, 2025
10.0%
17.2M shares
SC 13G/A · Nov 14, 2025
10.0%
17.2M shares
SC 13G · Oct 29, 2025
2.7%
4.7M shares
Suvretta Capital Management, LLC
SC 13G/A · Aug 21, 2025
8.2%
14.1M shares
SC 13D/A · Aug 18, 2025
4.5%
7.8M shares
SC 13D/A · Aug 15, 2025
8.9%
15.2M shares
SC 13G/A · Aug 14, 2025
9.8%
13.5M shares
Suvretta Capital Management, LLC
SC 13G · Aug 14, 2025
5.2%
7.1M shares
SC 13G/A · Aug 12, 2025
4.1%
5.6M shares
SC 13G/A · Jul 16, 2025
4.6%
6.4M shares
SC 13G/A · May 15, 2025
8.0%
11.1M shares
SC 13D/A · Apr 11, 2025
11.0%
15.2M shares
SC 13G · Feb 14, 2025
6.2%
8.6M shares
Adage Capital Management, L.P.
SC 13G/A · Feb 12, 2025
4.4%
6.0M shares
SC 13G · Feb 4, 2025
5.0%
6.9M shares
SC 13G · Jan 16, 2025
5.4%
7.4M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Nov 14, 2024
1.3%
1.8M shares
Blackstone Annex Master Fund L.P.
SC 13G · Aug 2, 2024
2.6%
3.6M shares
SC 13D/A · Mar 22, 2024
13.7%
18.8M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G · Feb 1, 2024
6.0%
7.6M shares
SC 13G · Nov 27, 2023
5.7%
7.2M shares
Rock Springs Capital Management LP
SC 13G/A · Feb 14, 2023
4.2%
5.3M shares
Foresite Capital Fund V, L.P. (“FCF V”)
SC 13G/A · Feb 13, 2023
3.5%
4.4M shares
SC 13D/A · Nov 10, 2022
14.9%
18.8M shares
Rock Springs Capital Management LP
SC 13G/A · Feb 14, 2022
5.4%
5.3M shares